Migraine and motion sickness: What is the link?

Progress in Neurobiology

Volumn 91, Issue 4, 2010, Pages 300-312

  Cuomo Granston, Anna ^a   Drummond, Peter D ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

Migraine; Motion sickness; Serotonin

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROTRANSMITTER; SEROTONIN;

BRAIN REGION; BRAIN STEM; BRAIN TISSUE; COMORBIDITY; DISEASE ASSOCIATION; DIZZINESS; ELECTROENCEPHALOGRAM; EXCITABILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOTHALAMUS; MESENCEPHALON; MIGRAINE; MOTION SICKNESS; NAUSEA; NOCICEPTION; NOCICEPTIVE STIMULATION; PAIN; PHYSIOLOGY; PRIORITY JOURNAL; REFLEX; REVIEW; SENSORY SYSTEM; SOLITARY TRACT NUCLEUS; STRESS; SYMPTOM; TRIGEMINAL NERVE; VASCULAR DISEASE; VERTIGO; VESTIBULAR DISORDER; VOMITING; ANIMAL; COMPLICATION; GASTROINTESTINAL DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN STEM; GASTROINTESTINAL DISEASES; HUMANS; HYPOTHALAMUS; MIGRAINE DISORDERS; MOTION SICKNESS; SEROTONIN; VASCULAR DISEASES; VESTIBULAR DISEASES;

EID: 77954217884     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.04.001     Document Type: Review

References (202)

1. Afra J., Proietti Cecchini A., Sandor P.S., Schoenen J. Comparison of visual and auditory evoked potentials in migraine patients between attacks. Clin. Neurophysiol. 2000, 111:1124-1129.
2. Afridi S.K., Giffin N.J., Kaube H., Friston K.J., Ward N.S., Frackowiak R.S.J., et al. A positron emission tomographic study in spontaneous migraine. Arch. Neurol. 2005, 62:1270-1275.
3. Afridi S.K., Matharu M.S., Lee L., Kaube H., Friston K.J., Frackowiak R.S.J., Goadsby P.J. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005, 128:932-939.
4. Andrews P.L.R. Physiology of nausea and vomiting. Br. J. Anaes. 1992, 69(Suppl. 1):2S-19S.
5. Arbab M.A-R., Wiklund L., Svendgaard N.A. Origin and distribution of cerebral vascular innervation from superior cervical, trigeminal and spinal ganglia with retrograde and anterograde WGA-HRP tracing in the rat. Neuroscience 1986, 19:695-708.
6. Bahra A., Matharu M.S., Buchel C., Frackowiak R.S., Goadsby P.J. Brainstem activation specific to migraine headache. Lancet 2001, 357:1016-1017.
7. Balaban C.D., Beryozkin G. Vestibular nucleus projections to nucleus tract solitaris and the dorsal motor nucleus of the vagus nerve: potential substrates for vestibulo-autonomic interactions. Exp. Brain Res. 1994, 98:200-212.
8. Baloh R.W. Neurotology of migraine. Headache 1997, 37:615-621.
9. Baloh R.W., Foster C.A., Yue Q., Nelson S.F. Familial migraine with vertigo and essential tremor. Neurology 1996, 46:458-460.
10. Barabas G., Matthews W.S., Ferrari M. Childhood migraine and motion sickness. Pediatrics 1983, 72(2):188-190.
11. Barber W.D., Yuan C. Gastric-vagal splanchnic interactions in the brainstem of the cat. Brain Res. 1989, 487:1-8.
12. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol. 1995, 46:575-605.
13. Benarroch E.E. Pain-autonomic interactions. Neurol. Sci. 2006, 27(Suppl. 2):S130-S133.
14. Benson A. Motion sickness. Aspects of Harsh Environments 2002, vol. 2:1048-1083. Walter Reed Army Medical Center, Washington DC, http://www.bordeninstitute.army.mil/published_volumes/harshEnv2/HE2ch35.pdf (Chapter 35).
15. Bijveld M.M.C., Bronstein A.M., Golding J.F., Gresty M.A. Nauseogenicity of off-vertical axis rotation vs. equivalent visual motion. Aviat. Space Environ. Med. 2008, 79(7):661-665.
16. Blair R.W. Noxious cardiac input onto neurons in medullary reticular formation. Brain Res. 1985, 326:335-346.
17. Blau J.N. What some patients can eat during migraine attacks: therapeutic and conceptual implications. Cephalalgia 1993, 13(4):293-295.
18. Blau J.N., MacGregor E.A. Is abdominal pain a feature of adult migraine?. Headache 1995, 35(4):207-209.
19. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nature Med. 2002, 8(2):136-142.
20. Borsook D., Burstein R., Moulton E., Becerra L. Functional imaging of migraine and the trigeminal system. Headache 2006, 46(Suppl. 1):S32-S38.
21. Boscan P., Kasparov K., Paton F.R. Somatic nociception activates NK1 receptors in the nucleus tractus solitarii to attenuate the baroreceptor cardiac reflex. Eur. J. Neurosci. 2002, 16:907-920.
22. Botney M. An inquiry into the genesis of migraine headache. Headache 1981, 21:179-185.
23. Burstein R., Cutrer M.F., Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nocieptive neurons in migraine. Brain 2000, 123(8):1703-1709.
24. Burstein R., Collins B., Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol. 2004, 55:19-26.
25. Burstein R., Jakubowski M. Analgesic triptan action in an animal model of intracranial pain; a race against the development of central sensitization. Ann. Neurol. 2004, 55:27-36.
26. Buzzi M.G., Bonamini M., Moskowitz M.A. Neurogenic model of migraine. Cephalalgia 1995, 15:277-280.
27. Buzzi M.G., Moskowitz M.A. The pathophysiology of migraine: year 2005. J. Headache Pain 2005, 6:105-111.
28. Caputi C.A., Firetto V. Therapuetic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 1997, 37:174-179.
29. Carrive P., Bandler R. Control of extracranial and hindlimb bloodflow by the midbrain periaqueductal grey of the cat. Exp. Brain Res. 1991, 84:599-606.
30. Cass S.P., Ankerstjerne J.K.P., Yetiser S., Furman J.M., Balaban C., Aydogan B. Migraine-related vestibulopathy. Annals Otol. Rhinol. Laryngol. 1997, 106:182-189.
31. Celik Y., Ekuklu G., Tokuc B., Utku U. Migraine prevalence and some related factors in Turkey. Headache 2005, 45:26-32.
32. Cha Y.H., Lee H., Santell L.S., Balch R.W. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia 2009, 29:550-555.
33. Crampton G.H. Motion and Space Sickness 1990, CRC Press, Inc., Boca Raton, Florida.
34. Cuomo-Granston A. Doctor of Philosophy Thesis: Motion Sickness, Pain and Migraine: Effects on Symptoms and Scalp Blood Flow 2008, Murdoch University Health Sciences: School of Psychology, Perth, WA.
35. Cuomo-Granston A. Motion Sickness, Pain and Migraine: Effects on Symptoms and Scalp Blood Flow 2009, Verlag VDM, Germany.
36. Cutrer F.W., Baloh R.W. Migraine-associated dizziness. Headache 1992, 32(June):300-304.
37. Dahlöf C.G.H., Hargreaves R.J. Pathophysiology and pharmacology of migraine: is there a place for antiemetics in future treatment strategies?. Cephalalgia 1998, 18:593-604.
38. Debney L.M. Visual stimuli as migraine trigger factors. Progress in Migraine Research 1984, vol. II:30-54. Pitman Press, Bath.
39. Denuelle M., Fabre N., Payoux P., Chollet F., Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007, 47:1418-1426.
40. Diagne M., Valla J., Delfini C., Buisseret-Delmas C., Buisseret P. Trigeminovestibular and trigeminospinal pathways in rats: retrograde tracing compared with glutamic acid decarboxylase and glutamate immunohistochemistry. J. Comp. Neurol. 2006, 496:759-772.
41. Diener H.C. Positron emission tomography in headache. Headache 1997, 37:622-625.
42. Diener H.C. How can PET scans help us understand headache mechanisms?. Cephalalgia 1999, 23:15-18.
43. Dichgans M., Freilinger T., Eckstein G., Babinin E., Lorenz-Depiereuz B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M.J.M., Pusch M., Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366:371-377.
44. Drummond P.D. Extracranial and cardiovascular reactivity in migrainous subjects. J. Psychosom. Res. 1982, 26:317-331.
45. Drummond P.D. A quantitative assessment of photophobiain migraine and tension headache. Headache 1986, 26(9):465-469.
46. Drummond P.D. Scalp tenderness and sensitivity to pain in migraine and tension headache. Headache 1987, 27(1):45-50.
47. Drummond P.D. Photophobia and autonomic responses to facial pain in migraine. Brain 1997, 120:1857-1864.
48. Drummond P.D. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalalgia 2002, 22:1-8.
49. Drummond P.D. Triggers of motion sickness in migraine sufferers. Headache 2005, 45:653-656.
50. Drummond P.D. Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology 2005, 65:620-622.
51. Drummond P.D. Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia 2006, 26:1225-1233.
52. Drummond P.D., Granston A. Facilitation of extracranial vasodilation to limb pain in migraine sufferers. Neurology 2003, 61:60-63.
53. Drummond P.D., Granston A. Facial pain increases nausea and headache during motion sickness in migraine sufferers. Brain 2004, 127:526-534.
54. Drummond P.D., Granston A. Painful stimulation of the temple induces nausea, headache and extracranial vasodilatation in migraine sufferers. Cephalalgia 2005, 25:16-22.
55. Drummond P.D., Lance J.W. Extracranial vascular changes and the source of pain in migraine headache. Ann. Neurol. 1983, 13:32-37.
56. Drummond P.D., Lance J.W. Neurovascular disturbances in headache patients. Clin. Exp. Neurol. 1984, 20:93-99.
57. Drummond P.D., Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia 1993, 13:321-324.
58. d'Onofrio F., Cologno D., Buzzi M.G., Petretta V., Caltagirone C., Casucci G., Bussone G. Adult abdominal migraine: a new syndrome or sporadic feature of migraine headache? A case report. Eur. J. Neurol. 2006, 13:85-88.
59. Dzoljic E., Sipetic S., Vlajinac H., Marinkovic J., Brzakovic B., Pokrajac M., Kostic V. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002, 42:185-193.
60. Edvinsson L., Ekman R., Jansen I., McCullock L., Uddman R. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J. Cerebral Blood Flow Metab. 1987, 7:720-728.
61. Edvinsson L., Uddman R. Neurobiology in primary headaches. Brain Res. Rev. 2005, 48:438-456.
62. Estevez M. Invertegrate modeling of a migraine channelopathy. Headache 2006, 46(Suppl. 1):S25-S31.
63. Evans R.W., Baloh R.W. Episodic vertigo and migraine. Headache 2001, 41:604-605.
64. Evers S., Quibeldey F., Grotemeyer K.H., Suhr B., Husstedt I.W. Dynamic changes of cognition habituation and serotonin metabolism during the migraine interval. Cephalalgia 1999, 19:486-491.
65. Fernandez-de-las-Penas C., Arendt-Nielsen L., Cuadrado M.L., Pareja J.A. Generalized mechanical pain sensitivity over nerve tissues in patients with strictly unilateral migraine. Clin. J. Pain 2009, 25(5):401-406.
66. Fernandez-de-Las-Penas C., Cuadrado M.L., Arendt-Nielsen L., Pareja J.A. Side-to-side differences in pressure pain thresholds and pericranial muscle tenderness in strictly unilateral migraine. Eur. J. Neurol. 2008, 15(2):162-168.
67. Ferrari M.D., Saxena P.R. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993, 13:151-165.
68. Fontes Ribeiro C.A., Cotrim M.D., Morgadinho M.T., Ramos M.I., Seabra Santos E., Macedo T.R.A. Migraine, serum serotonin and 5-HT2 receptors. Cephalalgia 1990, 10:213-219.
69. Fur J.L., Wang S.J., Lu S.R., Juang K.D. Ice-cream headache: a large survey of 8359 adolescents. Cephalalgia 2003, 23(10):977-981.
70. Gardner K.L. The genetic basis of migraine: how much do we know?. Can. J. Neurol. Sci. 1999, 26(Suppl. 3):S37-S43.
71. Gardner K.L. Genetics of migraine: an update. Headache 2006, 46(Suppl. 1):S19-S24.
72. Gerstner H.B. Reactions to short-term radiation in man. Annu. Rev. Med. 1960, 11:289-302.
73. Goadsby P.J. Brainstem activation of the adrenal medulla in the cat. Brain Res. 1985, 327:241-248.
74. Goadsby P.J. Migraine, aura, and cortical spreading depression: why are we still talking about it?. Ann. Neurol. 2001, 49(2):4-6.
75. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 1990, 28(2):183-187.
76. Goadsby P.J., Lambert G.A., Lance J.W. Stimulation of the trigeminal ganglion increases flow in the extracerebral but not the cerebral circulation of the monkey. Brain Res. 1986, 381:63-67.
77. Golding J.F. Phasic skin conductance activity and motion sickness. Aviat. Space Environ. Med. 1992, 63(3):165-171.
78. Golding J.F. Predicting individual differences in motion sickness susceptibility by questionnaire. Pers. Indiv. Diff. 2006, 41:237-248.
79. Golding J.F., Kadzere P., Gresty M.A. Motion sickness susceptibility fluctuates through the menstrual cycle. Aviat. Space Environ. Med. 2005, 76(10):970-973.
80. Granston A., Drummond P.D. 14th Migaine trust platform presentations, abstracts: the association between nausea and head pain in migraine sufferers. Cephalalgia 2002, 22:570-580. number 7.5, p. 578.
81. Granston A., Drummond P.D. Painful stimulation of the temple during optokinetic stimulation triggers migraine-like attacks in migraine sufferers. Cephalalgia 2005, 25:219-224.
82. Graves T.D., Imbrici P., Kors E.E., Terwindt G.M., Eunson L.H., Frants R.R., Haan J., Ferrari M.D., Goadsby P.J., Hanna M.G., van den Maagdenberg A.M., Kullmann D.M. Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2. Neurobiol. Dis. 2008, 32(1):10-15.
83. Grunfeld E., Gresty M.A. Relationship between motion sickness, migraine and menstruation in crew members of a 'round the world' yacht race. Brain Res. Bull. 1998, 47(5):433-436.
84. Gupta V.K. Menstrual migraine is not pathogenetically related to menstrual syndrome. Cephalalgia 1994, 14:411-412.
85. Gupta V.K. Migraine and sex hormones: epidemiological data stimulate rethinking of etiologic role of estrogen. Headache 2004, 44:933-934.
86. 1) in the living human brain using positron emission tomography. J. Clin. Psychiatry 2006, 63(Suppl. 11):18-24.
87. Harm D.L. Physiology of motion sickness symptoms. Motion and Space Sickness 1990, 153-177. C.R.C. Press, Inc., Boca Raton, Florida. G.H. Crampton (Ed.).
88. Harm D.L., Beatty B.J., Reschke M.F. Motion and Space Sickness 1987, 153-177. C.R.C. Press, Inc., Boca Raton, Florida. G.H. Crampton (Ed.).
89. Harris A.J. Cortical origin of pathological pain. Lancet 1999, 354:1464-1466.
90. Hasler W. Serotonin recepter physiology: relation to emesis. Digest. Dis. Sci. 1999, 44(Suppl.):108S-113S.
91. Headache Classification Subcommittee of the International Headache Society, 2004. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 24 (Suppl. 1), 9-160.
92. Herzog G.H. Neuroactive properties of reproductive steroids. Headache 2007, 47(Suppl. 2):S68-S78.
93. Ho T.W., Ferrari M.D., Dodick D.W., Galet V., Kost J., Fan X., Leibensperger H., Froman S., Assaid C., Lines C., Koppen H., Winner P.K. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitripan for acute migraine: a randomized, placebo controlled, parallel-treatment trial. Lancet 2008, 372(9656):2115-2123.
94. Horn C.C. Why is the neurobiology of nausea and vomiting so important?. Appetite 2008, 50:430-434.
95. Horn C.C., Ciucci M., Chaudhury A. Brain Fos expression during 48h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton. Neurosci. 2007, 132:44-51.
96. Horton, J., 2010. Migraine headache relief: does vomiting work? Is self-induced vomiting okay for migraine headache relief? Online: http://www.associatedcontent.com/article/2664877/migraine_headache_relief_does_vomiting.html.
97. Hoskin K.L., Lambert G.A., Donaldson C., Zagami A.S. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Res. 2004, 998:91-99.
98. Hunt S.P., Pini A., Evans G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328(6131):632-634.
99. Igarashi M. Motion and Space Sickness 1990, CRC. Press, Inc, Boca Raton: Florida. G.H. Crampton (Ed.).
100. Iversen H.K., Nielsen T.H., Olesen J., Tfelt-Hansen P. Arterial responses during migraine headache. Lancet 1990, 336:837-839.
101. Jan M.M.S. History of motion sickness is predictive of childhood migraine. J. Paediatr. Child Health 1998, 34:483-484.
102. Jan M.M.S., Camfield P.R., Gordon K., Camfield C.S. Vomiting after mild head injury is related to migraine. J. Pediatr. 1997, 130:134-137.
103. Javid F.A., Naylor R.J. The effect of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus. Pharmacol. Biochem. Behav. 2006, 85(4):820-826.
104. Jen J.C., Wan J., Palos T.P., Howard B.D., Baloh R.W. Mutations in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegic, and seizures. Neurology 2005, 65:529-534.
105. Katsarava Z., Giffin N., Diener H.C., Kaube H. Abnormal habituation of 'nociceptive' blink reflex in migraine: evidence for increased excitability of trigeminal nociception. Cephalalgia 2003, 23(8):814-819.
106. Kaube H., Katsarava Z., Przywara S., Drepper J., Ellrich J., Diener H.C. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus?. Neurology 2002, 58(8):1234-1238.
107. Kishimoto T., Sasa M., Takaori S. Inhibition of lateral vestibular nucleus neurons by 5-hydroxytryptamine derived from the dorsal ralphe nucleus. Brain Res. 1991, 553:229-237.
108. Knight Y. Brainstem modulation of caudal trigeminal nucleus: a model for understanding migraine biology and future drug targets. Headache Curr. 2005, 2(5):108-118.
109. Kolev O.I., Möller C., Nilsson G., Tibbling L. Responses in skin microcirculation to vestibular stimulation before and during motion sickness. Can. J. Neurol. Sci. 1997, 24:53-57.
110. Kowacs P.A., Piovesan E.J., Werneck L.C., Tatsui C.E., Lange M.C., Ribas L.C., da Silva H.P. Influence of intense light stimulation on trigeminal and cervical pain perception thresholds. Cephalalgia 2001, 21:184-188.
111. Kowalski A., Rapps N., Enck P. Functional cortical imaging of nausea and vomiting: a possible approach. Auton. Neurosci. 2006, 129:28-35.
112. Kuritzky A., Ziegler D.K., Hassanein R. Vertigo, motion sickness and migraine. Headache 1981, 21:227-231.
113. Ladabuam U., Hasler W.L. Novel approaches to the treatment of nausea and vomiting. Digest. Dis. 1999, 17:125-132.
114. Lambert G.A., Bogduk N., Goadsby P.J., Duckworth J.W., Lance J.W. Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J. Neurosurg. 1984, 61:307-315.
115. Lambert G.W., Zagami A.S. The mode of action of migraine triggers: a hypothesis. Headache 2009, 49:253-275.
116. Lance J.W. Headache: classification, mechanism and principles of therapy, with particular reference to migraine, Recenti Prog. Med. 1989, 80(12):673-680.
117. Lance J.W. Current concepts of migraine pathogenesis. Neurology 1993, 43(Suppl. 3):S11-S15.
118. Lance J.W., Goadsby P.J. Mechanism and Management of Headache 2005, Elsevier, New York. 7th ed.
119. Lance J.W., Lambert G.A., Goadsby P.J., Duckworth J.W. Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 1983, 23:258-265.
120. Lang I.V. Noxious stimulation of emesis. Digest. Dis. Sci. 1999, 44(Suppl. 8):585-635.
121. Lee P.G., Hohman T.C., Cai F., Regalia J., Helke C.J. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Exp. Neurol. 2001, 170:149-161.
122. Lempert T., Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine. J. Neurol. 2009, 256:333-338.
123. Levine M.E., Chillas J.C., Stern R.M., Knox G.W. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrythmia and the symptoms of motion sickness. Aviat. Space Environ. Med. 2000, 71:1111-1114.
124. Levy D., Jakubowski M., Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5-HT 1B/1D receptor agonists. Proc. Natl. Acad. Sci. USA 2004, 101:4274-4279.
125. Li B.U.K., Murray R.D., Heitlinger L.A., Robbins J.L., Hayes J.R. Is cyclic vomiting syndrome related to migraine. J. Pediatr. 1999, 134:567-572.
126. Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br. J. Obstet. Gynaecol. 1995, 102:153-159.
127. Linde M. Migraine: a review and future directions for treatment. Acta. Neurol. Scand. 2006, 114:71-83.
128. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657.
129. Loder E., Rizzoli P., Golub J. Hormonal management of migraine associated with menses and the menopause: a clinical review. Headache 2007, 47(2):329-340.
130. Longhurst J.C., Tjen-A-Looi S.C., Fu L.W. Cardiac sympathetic afferent activation provoked by myocardial ischemia and reperfusion. Ann. N. Y. Acad. Sci. 2001, 940(1):74-95.
131. Lucot J.B. Effects of serotonin antagonists on motion sickness and its suppression by 8-OHDPAT in cats. Pharmacol. Biochem. Behav. 1989, 37:283-287.
132. Macfarlane R. New concepts of vascular headache. Ann. Royal Coll. Surg. Engl. 1993, 75:225-228.
133. MacGregor A. Managing Migraine in Primary Care 1999, Blackwell Science, London.
134. MacGregor E.A., Chia H., Vohrah R.C., Wilkinson M. Migraine and menstruation: a pilot study. Cephalalgia 1990, 10:305-310.
135. Marano E., Marcelli V., Di Stasio E., Bonuso S., Vacca G., Manganelle F., Marciano E., Perretti A. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache 2005, 45:325-331.
136. Marcus D.A., Furman J.M. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Med. Sci. Monit. 2006, 12:1-7.
137. Marcus D.A., Furman J.M., Balaban C.D. Motion sickness in migraine sufferers. Expert Opin. Pharmacother. 2005, 6(15):2691-2697.
138. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part 1. Headache 2006, 46:3-23.
139. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part 2. Headache 2006, 46:365-386.
140. Martin V.T., Wernke S., Mandell K., Ramadan N., Kao L., Bean J., Liu J., Zoma W., Rebar R. Defining the relationship between ovarian hormones and migraine headache. Headache 2005, 45:1190-1201.
141. May A. Headache: lessons learned from functional imaging. Br. Med. Bull. 2003, 65:223-234.
142. May A. New insights into headache: an update on functional and structural imaging techniques. Nat. Rev. Neurol. 2009, 5(4):199-209.
143. May A., Goadsby P.J. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cerebral Blood Flow Metab. 1999, 19:115-127.
144. May A., Bahra A., Büchel C., Frackowiak R.S.J., Goadsby P.J. Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
145. May A., Goadsby P.J. Substance P receptor antagonists in the therapy of migraine. Expert Opin. Invest. Drugs. 2001, 10(4):673-678.
146. Mayberg M., Langer R.S., Zervas N.T., Moskowitz M.A. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headache. Science 1981, 213:228-230.
147. McMillin D.L., Richards D.G., Mein E.A., Nelson C.D. The abdominal brain and enteric nervous system. J. Altn. Compl. Med. 1999, 5:6575-6586.
148. Medina J.L., Diamond S. Migraine and atopy. Headache 1976, 15(4):271-274.
149. Menėtrey D., Basbaum A.I. Spinal and trigeminal projections to the nucleus of the solitary tract: a possible substrate for somatovisceral and viscerovisceral reflex action. J. Comp. Neurol. 1987, 255:439-450.
150. Millan M.J. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
151. Mitchelson F. Pharmacological agents affecting emesis. Drugs 1992, 43(3):295-315.
152. Money K.E. Motion and Space Sickness 1990, CRC Press, Inc, Boca Raton: Florida. G.H. Crampton (Ed.).
153. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993, 43(Suppl. 3):S16-S20.
154. Moskowitz M.A. The neurobiology of vascular head pain. Ann. Neurol. 1984, 16:157-168.
155. Neuhauser R., Radtke A., Von Brevern M., Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003, 60(5):882-883.
156. Newman L.C. Understanding the causes and prevention of menstrual migraine: the role of estrogen. Headache 2007, 47(Suppl. 2):S86-S94.
157. O'Connor T.P., van der Kooy D. Pattern of intracranial and extracranial circulatory projections of trigeminal ganglion cells. J. Neurosci. 1986, 6:2200-2207.
158. Okada F., Saito H., Matsuki N. Prophylactic effect of serotonin uptake inhibitors against motion sickness in Suncus murinus. Eur. J. Pharmacol. 1996, 309:33-35.
159. 1A receptor agonists in Suncus murinus. Japn. J. Pharmacol. 1994, 64:109-114.
160. Olesen J. Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache 1978, 18(5):268-271.
161. Olesen J., Diener H.-C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., Lesko L.M. Calcitonion-gene related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. New Engl. J. Med. 2004, 350:1104-1110.
162. Olesen J., Friberg L., Skyhøj Olsen T., Iversen H.K., Lassen N.A., Andersen A.R., Karle A. Timing and topography of cerebral flow, aura and headache during migraine attacks. Ann. Neurol. 1990, 28(6):791-798.
163. Pascual J., del Arco C., Romon T., del Omo E., Castro E., Pazos A. Autoradiographic distribution of [3H] sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996, 16:317-322.
164. Passchier J.A. Critical note on psychophysiological stress research into migraine patients. Cephalalgia 1994, 14:194-198.
165. Peroutka S.J. Neurogenic inflammation and migraine: implication for therapeutics. Mol. Intervent. 2005, 5(5):304-311.
166. Peroutka S.J., Wilhoit T., Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 1997, 49:201-206.
167. Proceta J.S., Dalessio D.J. Identification and treatment of sleep apnea in patients with chronic headache. Headache 1995, 35:586-589.
168. Raskin N.H., Hosobuchi Y., Lamb S. Headache may arise from perturbation of brain. Headache 1987, 27:416-420.
169. Raskin N.H., Knittle S.C. Ice cream headache and orthostatic symptoms in patients with migraine. Headache 1976, 16(5):222-225.
170. Raskin N.H., Schwartz R.K. Icepick-like pain. Neurology 1980, 30(2):203-205.
171. Rasmussen B.K. Epidemiology of migraine. Cephalalgia 1995, 15:45-68.
172. Rasmussen B.K., Jensen R., Olesen J.A. Population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991, 11(3):129-134.
173. Reavley C.M., Golding J.F., Cherkas L.F., Spector T.D., MacGregor A.J. Genetic influences on motion sickness susceptibility in adult women: a classical twin study. Aviat. Space Environ. Med. 2006, 77(11):1148-1152.
174. 3 antagonist ondansetron, hyocine and placebo in the prevention of motion-induced nausea in man. Br. J. Clin. Pharmacol. 2000, 50:61-64.
175. Reid K., Sciberras D.G., Gertz B.J., Reinhardt R.R., Lui G., Golding J.F., Stott J.R.R. Comparison of a neurokinin-1 antagonist, l-758,298, and scopolamine with placebo in the prevention of motion-induced nausea in man. Br. J. Clin. Pharmacol. 1998, 46:22-24. 282 P.
176. Reynolds D.J., Hovanitz C.A. Life events and headache frequency revisited. Headache 2000, 40:111-118.
177. Sandrini G., Proietti Cecchini A., Milanov I., Tassorelli C., Buzzi M.G., Nappi G. Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci. Lett. 2002, 317(3):135-138.
178. Sanger G.J., Andrews P.L. Treatment of nausea and vomiting: gaps in our knowledge. Auton. Neurosci. 2006, 129:3-16.
179. Scharff L., Turk D.C., Marcus D.A. Triggers of headache episodes and coping responses of headache diagnosis groups. Headache 1995, 35(7):397-403.
180. Schoonman G.G., van der, Grond J., Kortmann C., van der Geest R.J., Terwindt G.M., Ferrari M.D. Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study. Brain 2008, 131:2192-2200.
181. Selekler H.M., Erdogan M.S., Budak F. Prevalence and clinical characteristicsof an experimental model of 'ice-cream headache' in migraine and episodic tension-type headache patients. Cephalalgia 2004, 24(4):293-297.
182. Silberstein S.D. Serotonin (5-HT) and migraine. Headache 1994, 34:408-417.
183. Silberstein S.D. Neurotoxins in the neurobiology of pain. Headache 2003, 43(Suppl. 1):S2-S8.
184. Silberstein S.D., Merriam G. Physiology of the menstrual cycle. Cephalalgia 2000, 20:148-154.
185. Gray's Anatomy: the Anatomical Basis of Clinical Practice 2005, Elsevier Churchill Livingstone, London. S. Standring (Ed.).
186. Stern R.M. Asian hypersusceptibility to motion sickness. Human Hered. 1996, 46:7-14.
187. Takeda N., Morita M., Hasegawa S., Horii A., Kubo T., Matsunaga T. Neuropharmacology of motion sickness and emesis. Acta Otolarngol. Suppl. 1993, 501:10-15.
188. Takeda N., Morita M., Horii A., Nishiike S., Kitahara T., Uno A. Neural mechanisms of motion sickness. J. Med. Invest. 2001, 48:44-59.
189. Triesman M. Motion sickness: an evolutionary hypothesis. Science 1977, 197:493-495.
190. Vanagaite J., Parej J.A., Storen O., White L.R., Sand T., Stovner L.J. Light induced discomfort and pain in migraine sufferers. Cephalalgia 1997, 17(7):733-741.
191. Vincent M., Hadjikhani N. The cerebellum and migraine. Headache 2007, 47(6):820-833.
192. Vingen J.V., Pareja J.A., Storen O., White L.R., Stovner L.J. Phonophobia in migraine. Cephalalgia 1998, 18(5):243-249.
193. von Brevern M., Zeise D., Neuhauser H., Clarke A.H., Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain 2005, 128:365-374.
194. Weiller C., May A., Limmroth V., Jǔptner M., Kaube H., Schayck R.V., Coenen H.H., Diener H.C. Brain stem activation in spontaneous human migraine attacks. Nature Med. 1995, 1(7):658-660.
195. Williamson D.J., Hargreaves R.J. Neurogenic inflammation in the context of migraine. Microsc. Res. Tech. 2001, 53:167-178.
196. Weissman-Fogel I., Specher E., Granovsky Y., Yarnitsky D. Repeated noxious stimulation of the skin enhances cutaneous pain perception of migraine patients in-between attacks: clinical evidence for continuous sub-threshold increase in membrane excitability of central trigeminovascular neurons. Pain 2003, 104(3):693-700.
197. Wolff H.G. Headache and Other Head Pain 1948, Oxford University Press, New York. 1st ed.
198. Wolff H.G. Headache and Other Head Pain 1972, Oxford University Press, New York, Revised by Dalessia, D.J. 3rd ed.
199. Yarnitsky D., Goor-Aryeh I., Bajwa Z.H., Ransil B.I., Cutre F.M., Sottile A., Burstein R. Wolff Award: possible parasympathetic contributions to peripheral and central sensitisation during migraine. Headache 2003, 43:704-714.
200. Yates B.J., Grėlot L., Kermon A., Balaban C.D., Jakuš J., Miller A.D. Organization of vestibular inputs to nucleus tractus solitarius and adjacent structures in cat brain stem. Am. J. Physiol. Reg. Integrat. Comp. Physiol. 1994, 267:974-983.
201. Yates B.J., Miller A.D., Lucot J.B. Physiological basis and pharmacology of motion sickness: an update. Brain Res. Bull. 1998, 47(5):395-406.
202. Zerari-Mailly F., Buisseret P., Buisseret-Delmas C., Nosjean A. Trigemino-solitarii-facial pathway in rats. J. Comp. Neurol. 2005, 487:176-189.